Istituto Nazionale Tumori Fondazione G. Pascale

Fingerprint Dive into the research topics where Istituto Nazionale Tumori Fondazione G. Pascale is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.

Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Melanoma Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Survival Medicine & Life Sciences
Italy Medicine & Life Sciences
Non-Small Cell Lung Carcinoma Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Profiles

No photo of Valentina Abate

Valentina Abate

Person: Academic

20152019
No photo of Rosanna Accardo

Rosanna Accardo

Person: Academic

19992019
No photo of Domingo Alberti

Domingo Alberti

Person: Academic

20022017

Projects 2019 2019

PASCALE - TRATTAMENTI INTEGRATI IN ONCOLOGIA

Ricerca, U.

1/1/19 → 12/31/19

Project: Other project

PASCALE - STRATEGIE TERAPEUTICHE INNOVATIVE NELLA MALATTIA AVANZATA

Ricerca, U.

1/1/19 → 12/31/19

Project: Other project

PASCALE - PREVENZIONE E FATTORI DI RISCHIO NELLA PATOLOGIA NEOPLASTICA

Ricerca, U.

1/1/19 → 12/31/19

Project: Other project

Research Output 1977 2020

Final results from GCIG/ENGOT/AGO-OVAR 12, a randomised placebo-controlled phase III trial of nintedanib combined with chemotherapy for newly diagnosed advanced ovarian cancer

on behalf of the AGO Study Group-led GCIG/ENGOT Intergroup Consortium, 2020, In : International Journal of Cancer.

Research output: Contribution to journal › Article

Ovarian Neoplasms
Placebos
Drug Therapy
Survival
Gynecology

18F-FACBC in prostate cancer: A systematic review and meta-analysis

Young AIMN Working Group, Jan 1 2019, In : Cancers. 11, 9, 11091348.

Research output: Contribution to journal › Review article

Open Access
Meta-Analysis
Prostatic Neoplasms
Prostatic Diseases
Prostate-Specific Antigen
Positron-Emission Tomography

18F-FDG PET/CT Is an Early Predictor of Pathologic Tumor Response and Survival to Preoperative Radiochemotherapy with Bevacizumab in High Risk Locally Advanced Rectal Cancer

Avallone, A., Aloj, L., Pecori, B., Caraco, C., De Stefano, A., Tatangelo, F., Silvestro, L., Granata, V., Bianco, F., Romano, C., Di Gennaro, F., Budillon, A., Petrillo, A., Muto, P., Botti, G., Delrio, P. & Lastoria, S., 2019, In : Journal of Nuclear Medicine.

Research output: Contribution to journal › Article

Fluorodeoxyglucose F18
Chemoradiotherapy
Rectal Neoplasms
Survival
Neoplasms